Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medivation Reports Third Quarter 2010 Financial Results and Provides Corporate Update
Yahoo/PR NewsWire
Saturday, November 6, 2010 - 12:51pm
tags:
Medivation, MDV3100, prostate cancer, PREVAIL trial
Sequenom Shares Popped: What You Need to Know
Motley Fool
Saturday, November 6, 2010 - 12:50pm
tags:
Sequenom
Bad Medicine: When Doctors Tip Off Wall Street
TheStreet.com
Friday, November 5, 2010 - 12:19pm
tags:
hedge funds, hepatitis C
MAP reports 3Q loss on lack of revenue
Yahoo/AP
Friday, November 5, 2010 - 12:18pm
tags:
earnings, MAP Pharmaceuticals
Roche melanoma drug shows promise in study
Reuters
Friday, November 5, 2010 - 11:57am
tags:
Roche, melanoma
Is Pfizer the Perfect Stock?
Motley Fool
Friday, November 5, 2010 - 11:34am
tags:
Pfizer
Halozyme Therapeutics 3Q loss narrows on revenue
Yahoo/AP
Friday, November 5, 2010 - 11:33am
tags:
earnings, Halozyme
Genzyme starts 1st phase of layoffs with 392 cuts
Yahoo/AP
Friday, November 5, 2010 - 11:32am
tags:
Genzyme, layoffs
GSK chief was right about tough-to-copy Advair
Fierce Pharma
Friday, November 5, 2010 - 11:23am
tags:
GSK, Advair, Teva Pharmaceuticals, generics, Andrew Witty
ThromboGenics Seeks Cash Deal on Clot Drug to Fund Microplasmin
Bloomberg
Friday, November 5, 2010 - 11:22am
tags:
anti-clotting, ThromboGenics
Pfizer Pill Leads Race to Dominate $12 Billion Arthritis Market
Bloomberg
Friday, November 5, 2010 - 11:21am
tags:
arthritis, Pfizer, tasocitinib
Could China Steal America’s Biotech Crown?
Forbes
Friday, November 5, 2010 - 11:20am
tags:
biotech, China, Quintiles
US Mid-Term Elections: What It Means for Pharma
PharmExec
Friday, November 5, 2010 - 11:16am
tags:
elections, pharma industry
Lilly Wins Backing to Use Antidepressant Cymbalta for Back, Arthritis Pain
Bloomberg
Friday, November 5, 2010 - 9:24am
tags:
Eli Lilly, Cymbalta, antidepressants, back pain, arthritis
Jazz posts $13M profit for third quarter
Bizjournals.com
Thursday, November 4, 2010 - 10:09pm
tags:
earnings, Jazz Pharmaceuticals
Targacept profit nearly doubles
Bizjournals.com
Thursday, November 4, 2010 - 10:07pm
tags:
earnings, Targacept
[video]Teva Performance Tough Pill to Swallow
CNBC
Thursday, November 4, 2010 - 10:02pm
tags:
Teva Pharmaceuticals
MannKind Falls After Lawsuit Alleges Unlawful Clinical Trial Conduct
Bloomberg
Thursday, November 4, 2010 - 10:00pm
tags:
MannKind, lawsuits, diabetes, fraud, Afrezza
Pfizer Bone Drug Reduces Breast Cancer Risk in Older Women
Bloomberg
Thursday, November 4, 2010 - 9:59pm
tags:
breast cancer, Pfizer, Fablyn
Are Monthly Numbers Necessary, Dendreon?
Motley Fool
Thursday, November 4, 2010 - 9:58pm
tags:
Dendreon, Provenge, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.